RECRUITING Not applicable ClinicalTrials.gov

Artificial Intelligence (AI) Assisted Real-time Adenoma Detection and Classification During Colonoscopies

Sponsor: Centre hospitalier de l'Université de Montréal (CHUM) • ClinicalTrials.gov ID: NCT05244278

Registry updated: 2026-09-21

Recruiting for Similar Conditions?

Sponsors are looking for patients like you. See if you qualify for compensated research studies.

Description

This is a pragmatic, double-blind, randomized, controlled trial, to evaluate the effect of implementing a Computer-assisted detection (CADe) system within the routine clinical practice of Canadian healthcare institutions. The main hypothesis of this study is that the ADR in the operating room equipped with the GI genius CADe system will be significantly higher than the ADR in the ordinary operating room.

Interventions

Medtronic-GI genius (CADe system for detecting colorectal polyps) (Device)
Medtronic-GI genius: AI will provide real-time feedback throughout each colonoscopy procedure and alert endoscopists to the presence of a polyp in the endoscopy field by displaying a bounding box on the same screen.

Eligibility criteria

Inclusion Criteria: * indication of undergoing a screening, surveillance, or diagnostic colonoscopy * Age 45-89 years Exclusion Criteria: * Patients undergoing emergency colonoscopy * Patients with a known familial polyposis syndrome or a known inflammatory bowel disease

Conditions

Artificial Intelligence

Locations

Centre Hospitalier Universitaire de Montréal — Montreal, Quebec, Canada

Partner with Nurenyx

Showcase your study to thousands of motivated patients matching your criteria.

Learn More

Official Source

Data sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

View Official Record

Accelerate Your Clinical Trial Recruitment